Skip to content

Heart Failure With Mildly Reduced Ejection Fraction Registry

Heart Failure With Mildly Reduced Ejection Fraction Registry (HARMER)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05603390
Acronym
HARMER
Enrollment
2200
Registered
2022-11-02
Start date
2015-01-01
Completion date
2023-01-01
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Heart failure (HF) affects about 1% of patients younger than 55 years, whereas the prevalence of HF increases \> 10% in patients with at least 70 years of age. Despite HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the clinical significance of HF with mildly reduced ejection fraction (HFmrEF) has gained more importance within the past years. Those patients are characterized by a left ventricular ejection fraction (LVEF) of 41-49%. However, within the current European guidelines, limited treatment recommendations in this subgroup of HF are yet available as a consequence of the limited number of studies in this field. The Heart Failure With Mildly Reduced Ejection Fraction Registry aims to characterize patients with HFmrEF and investigated the prognostic impact of interventional and pharmacological therapies in this subgroup of HF patients.

Interventions

None listed

Sponsors

Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with HFmrEF (i.e., LVEF 41-49%) * Patients with at least 18 years of age

Exclusion criteria

* Patients younger than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortality2 years.All-cause mortality

Secondary

MeasureTime frameDescription
Change of LVEF2 years.Change of LVEF
Change of NT-pro BNP2 years.Change of NT-pro BNP
Heart-failure related hospitalization2 years.Heart-failure related hospitalization

Countries

Germany

Contacts

Primary ContactMichael Behnes, MD
michael.behnes@umm.de+496213836239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026